Unspecified Adult Solid Tumor, Protocol SpecificNCT00670605
Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center
An observational study of Unspecified Adult Solid Tumor, Protocol Specific and Unspecified Childhood Solid Tumor, Protocol Specific, run by Vanderbilt University at 3 sites in United States.
Trial summary
RATIONALE: Gathering information about the number of young patients with cancer and the outcome of these patients may help doctors learn more about cancer. PURPOSE: This research study is looking at the medical records of young patients undergoing cancer treatment at the Vanderbilt-Ingram Cancer Center to determine… Read more about this study
- Who is it for?
- Ages 15 to 30 years
- Conditions the study is for
- Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
- What is being tested?
- medical chart review and study of socioeconomic and demographic variables
- How many people
- Not given
- Where
- 3 sitesUnited States
- Study dates
- Jun 2007to Dec 2009
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 30 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Newly diagnosed
DISEASE CHARACTERISTICS:
- Diagnosis of cancer
- Newly diagnosed disease from 1990 to 2005
- 15 to 30 years old at the time of cancer diagnosis
- Must live in the state of Tennessee
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Trial locations and contacts
3 sites in 1 country.
United States3 sites
Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee, 37064
Vanderbilt-Ingram Cancer Center at Franklin
Nashville, Tennessee, 37064
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232-6838
About this study
Official title: VICC Adolescent and Young Adult Oncology Review
RATIONALE: Gathering information about the number of young patients with cancer and the outcome of these patients may help doctors learn more about cancer.
PURPOSE: This research study is looking at the medical records of young patients undergoing cancer treatment at the Vanderbilt-Ingram Cancer Center to determine how often cancer occurs and the outcome of these patients.
Read the detailed description
OBJECTIVES:
- To determine the number of patients between 15 and 30 years old who are treated for newly diagnosed cancer at the Vanderbilt-Ingram Cancer Center (VICC), in middle Tennessee, and in the state of Tennessee between 1990 and 2005.
- To determine the outcomes of these patients.
- To determine the number of these patients enrolled on clinical trials at VICC.
- To compare the outcomes of these patients when treated on a trial versus not treated on a trial provided they have the same disease.
- To compare the number of these patients who are treated on a clinical trial when they are first seen at Vanderbilt Children's Hospital vs Vanderbilt University Hospital.
- To determine referral patterns of these patients to VICC.
- To compare the outcomes of these patients who are treated at VICC vs middle Tennessee vs the state of Tennessee vs the entire nation.
- To determine the reason for not enrolling on a clinical trial.
OUTLINE: Cancer cases taken from the Vanderbilt-Ingram Cancer Center (VICC) Registry and the Tennessee Cancer Registry are examined for number and types of cancer, mortality rates broken down by county and health department region, electronic medical records, and treatment outcomes. Data is analyzed for comparison of number of new cancer patients, mortality rates, and referral patterns at VICC versus number of new cancer patients in the region, state, and country.
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
- Being tested
- medical chart review, study of socioeconomic and demographic variables
- Keywords
- unspecified adult solid tumor, protocol specific, unspecified childhood solid tumor, protocol specific
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
medical chart reviewOther
study of socioeconomic and demographic variablesOther
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of patients with newly diagnosed cancer from 1990 to 2005 and treated at Vanderbilt-Ingram Cancer Center (VICC), in middle Tennessee, and the state of Tennessee
Comparison of outcomes
Number of patients enrolled in clinical trials at VICC
Outcomes of patients treated on a trial vs those not treated with the same disease
Comparison of number of patients treated at Vanderbilt Children's Hospital vs Vanderbilt University Hospital
Referral patterns
Reason for not enrolling on a clinical trial
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 May 2008 (estimated)
- Study startJun 2007
- Primary completionDec 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Unspecified Adult Solid Tumor, Protocol SpecificStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
Sponsor and investigators
- Lead sponsor
- Vanderbilt University
- Sponsor type
- University, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Investigators
- Anderson B. Collier, MD, Study chair, Vanderbilt Children's Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00670605
- Sponsor's protocol ID
- CDR0000584244
- Other IDs
- P30CA068485, VU-VICC-PED-0732, VU-VICC-070568
- Status last verified
- Mar 2011
- First submitted
- 1 May 2008
- Last updated
- 24 Mar 2011
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Mar 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- VICC Adolescent and Young Adult Oncology Review
- ClinicalTrials.gov ID
- NCT00670605
- Acronym / sponsor ID
- CDR0000584244
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
- Keywords
- unspecified adult solid tumor, protocol specific, unspecified childhood solid tumor, protocol specific
- Study type
- Observational
- Recruitment status
- Terminated
- Lead sponsor
- Vanderbilt UniversityUniversity, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Study start
- Jun 2007
- Primary completion
- Dec 2009 (actual)
- First posted
- 2 May 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
RATIONALE: Gathering information about the number of young patients with cancer and the outcome of these patients may help doctors learn more about cancer.
PURPOSE: This research study is looking at the medical records of young patients undergoing cancer treatment at the Vanderbilt-Ingram Cancer Center to determine how often cancer occurs and the outcome of these patients.
Detailed description
OBJECTIVES:
- To determine the number of patients between 15 and 30 years old who are treated for newly diagnosed cancer at the Vanderbilt-Ingram Cancer Center (VICC), in middle Tennessee, and in the state of Tennessee between 1990 and 2005.
- To determine the outcomes of these patients.
- To determine the number of these patients enrolled on clinical trials at VICC.
- To compare the outcomes of these patients when treated on a trial versus not treated on a trial provided they have the same disease.
- To compare the number of these patients who are treated on a clinical trial when they are first seen at Vanderbilt Children's Hospital vs Vanderbilt University Hospital.
- To determine referral patterns of these patients to VICC.
- To compare the outcomes of these patients who are treated at VICC vs middle Tennessee vs the state of Tennessee vs the entire nation.
- To determine the reason for not enrolling on a clinical trial.
OUTLINE: Cancer cases taken from the Vanderbilt-Ingram Cancer Center (VICC) Registry and the Tennessee Cancer Registry are examined for number and types of cancer, mortality rates broken down by county and health department region, electronic medical records, and treatment outcomes. Data is analyzed for comparison of number of new cancer patients, mortality rates, and referral patterns at VICC versus number of new cancer patients in the region, state, and country.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 15 to 30 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Newly diagnosed
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| medical chart review | Other | – |
| study of socioeconomic and demographic variables | Other | – |
Primary outcome
Number of patients with newly diagnosed cancer from 1990 to 2005 and treated at Vanderbilt-Ingram Cancer Center (VICC), in middle Tennessee, and the state of Tennessee
Comparison of outcomes
Number of patients enrolled in clinical trials at VICC
Outcomes of patients treated on a trial vs those not treated with the same disease
Comparison of number of patients treated at Vanderbilt Children's Hospital vs Vanderbilt University Hospital
Referral patterns
Reason for not enrolling on a clinical trial
Results and safety
The study was stopped early. Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Mar 2011.
Related trials for Unspecified Adult Solid Tumor, Protocol Specific
Active, not recruitingPhase 1
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists
Unspecified Adult Solid Tumor, Protocol Specific
Active, not recruiting
Assessment Tool for Older Patients With Cancer
Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment
Active, not recruiting
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
Breast Cancer, Colon Cancer
Recruiting
Copenhagen Prospective Personalized Oncology (CoPPO)
Unspecified Adult Solid Tumor, Protocol Specific
Active, not recruiting
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anderson B. Collier, MD study chair
Vanderbilt Children's Hospital
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Unspecified Adult Solid Tumor, Protocol Specific and Unspecified Childhood Solid Tumor, Protocol Specific, run by Vanderbilt University at 3 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 24 Mar 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early. Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of patients with newly diagnosed cancer from 1990 to 2005 and treated at Vanderbilt-Ingram Cancer Center (VICC), in middle Tennessee, and the state of Tennessee. The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2011.